Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: From review to preview
- 1 February 2015
- journal article
- review article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 129, 1-9
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- Evaluation of the neuroprotective effect of dextromethorphan in the acute phase of ischaemic strokeArchives of Medical Science, 2011
- NXY-059 for the Treatment of Acute StrokeStroke, 2008
- Sulfonylureas Improve Outcome in Patients With Type 2 Diabetes and Acute Ischemic StrokeStroke, 2007
- A Review of the Neuroprotective Properties of the 5-HT1A Receptor Agonist Repinotan HC1 (BAY × 3702) in Ischemic StrokeCNS Drug Reviews, 2006
- Newly expressed SUR1-regulated NCCa-ATP channel mediates cerebral edema after ischemic strokeNature Medicine, 2006
- Oral Citicoline in Acute Ischemic StrokeStroke, 2002
- Use of a Global Test for Multiple Outcomes in Stroke Trials With Application to the National Institute of Neurological Disorders and Stroke t-PA Stroke TrialStroke, 1996
- Safety and Tolerability of the Glutamate Antagonist CGS 19755 (Selfotel) in Patients With Acute Ischemic StrokeStroke, 1995
- Safety study of tirilazad mesylate in patients with acute ischemic stroke (STIPAS).Stroke, 1994